AC Immune
ACIU • NASDAQ • Stock Fundamentals
AC Immune is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Andrea Pfeifer, with a market cap of $230.0M.
Market Cap$230.0M
Employees161.0
CEOAndrea Pfeifer
CountrySwitzerland
Healthcare
Biotechnology
Most Recent EarningsApr 30, 2026 · 1 month 15 days agoQ1 2026
View reportNext EarningsAug 4, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
AC Immune FAQ
Common questions about AC Immune
AC Immune (ACIU) has a market capitalization of $230.0M and trades on NASDAQ.
AC Immune has approximately 161 employees.